The Causes and Outcomes of Early Relaparotomy Following Pediatric Living Donor Liver Transplantation.


Journal

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
ISSN: 1527-6473
Titre abrégé: Liver Transpl
Pays: United States
ID NLM: 100909185

Informations de publication

Date de publication:
07 2019
Historique:
received: 24 07 2018
accepted: 07 03 2019
pubmed: 14 3 2019
medline: 22 8 2020
entrez: 14 3 2019
Statut: ppublish

Résumé

Early relaparotomy of adult recipients after living donor liver transplantation (LDLT) is significantly associated with poor prognosis. However, there are few reports focusing on pediatric recipients after LDLT. The aim of this study is to clarify the causes and outcomes of early relaparotomy after pediatric LDLT. A total of 265 pediatric recipients (272 LDLTs) transplanted from May 2001 to October 2015 were retrospectively analyzed. Early relaparotomy was defined as surgical intervention performed within 3 months after LDLT. Early relaparotomy was performed 49 times for 33 recipients (12.5%). The recipient and graft survival rates in the early relaparotomy group were significantly lower than those in the nonearly relaparotomy group, respectively (75.0% and 63.6% versus 96.6% and 95.8%; both P < 0.001). Left lateral segment grafts were used significantly more frequently in the nonrelaparotomy group (P = 0.01). According to the multivariate analysis, the preoperative Pediatric End-Stage Liver Disease (PELD)/Model for End-Stage Liver Disease (MELD) score of the early relaparotomy group was significantly higher than that of the nonearly relaparotomy group (13.7 versus 6.3; P = 0.04). According to the receiver operating characteristic curve, the preoperative PELD/MELD score cutoff point was 17.2. Early relaparotomy due to infectious causes led to significantly poorer graft survival than that due to noninfectious causes (P = 0.04). In conclusion, the recipient and graft survival rates of the early relaparotomy group were significantly lower than those of the nonearly relaparotomy group. A high preoperative PELD/MELD score was a risk factor for early relaparotomy. In particular, early relaparotomy due to infection showed a poor prognosis.

Identifiants

pubmed: 30865366
doi: 10.1002/lt.25446
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1066-1073

Informations de copyright

Copyright © 2019 by the American Association for the Study of Liver Diseases.

Auteurs

Noriki Okada (N)

Departments of Transplant Surgery, Jichi Medical University Hospital, Jichi Medical University, Shimotsuke City, Japan.

Yukihiro Sanada (Y)

Departments of Transplant Surgery, Jichi Medical University Hospital, Jichi Medical University, Shimotsuke City, Japan.

Yasuharu Onishi (Y)

Departments of Transplant Surgery, Jichi Medical University Hospital, Jichi Medical University, Shimotsuke City, Japan.

Taizen Urahashi (T)

Departments of Transplant Surgery, Jichi Medical University Hospital, Jichi Medical University, Shimotsuke City, Japan.

Yoshiyuki Ihara (Y)

Departments of Transplant Surgery, Jichi Medical University Hospital, Jichi Medical University, Shimotsuke City, Japan.

Naoya Yamada (N)

Departments of Transplant Surgery, Jichi Medical University Hospital, Jichi Medical University, Shimotsuke City, Japan.

Yuta Hirata (Y)

Departments of Transplant Surgery, Jichi Medical University Hospital, Jichi Medical University, Shimotsuke City, Japan.

Takumi Katano (T)

Departments of Transplant Surgery, Jichi Medical University Hospital, Jichi Medical University, Shimotsuke City, Japan.

Toshimi Imai (T)

Pharmacology, Jichi Medical University Hospital, Jichi Medical University, Shimotsuke City, Japan.

Kentaro Ushijima (K)

Pharmacology, Jichi Medical University Hospital, Jichi Medical University, Shimotsuke City, Japan.

Keiko Ogaki (K)

Pharmacy, Jichi Medical University Hospital, Jichi Medical University, Shimotsuke City, Japan.

Shinya Otomo (S)

Pharmacy, Jichi Medical University Hospital, Jichi Medical University, Shimotsuke City, Japan.

Koichi Mizuta (K)

Departments of Transplant Surgery, Jichi Medical University Hospital, Jichi Medical University, Shimotsuke City, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH